Linked Life Data

1293653

Source:http://linkedlifedata.com/resource/pubmed/id/1293653

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1993-4-5
pubmed:abstractText
During the last years, the use of hemoderivatives has largely increased. Their use carries a high risk for post-transfusion reactions and for transmission of severe infectious diseases. In a high percentage of cases the use of these compounds is inadequate. At the present time there are pharmacologic (desmopressin, antifibrinolytics, vitamin K) and nonpharmacologic strategies (autotransfusion, hemodilution, intra and postoperative recovery of blood) directed to avoid or to decrease the need for transfusion. We review all these strategies and we propose some criteria for transfusion of plasma and platelets, as well as attitudes for particular situations.
pubmed:language
spa
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0034-9356
pubmed:author
pubmed:issnType
Print
pubmed:volume
39
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
355-61
pubmed:dateRevised
2009-11-11
pubmed:meshHeading
pubmed:articleTitle
[Indications for the use of platelets, plasma and anti-hemorrhagic drugs].
pubmed:affiliation
Servicio de Hematología y Hemoterapia, Hospital de la Santa Creu i Sant Pau, Barcelona.
pubmed:publicationType
Journal Article, English Abstract, Review